Catalyst Pharmaceuticals (CPRX) Treasury Shares (2014 - 2026)

Catalyst Pharmaceuticals has reported Treasury Shares for 10 years, with the latest figure at $615765.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $615765.0; the trailing twelve-month figure through Mar 2026 stood at $615765.0 (changed N/A YoY), and the FY2025 full-year result was $752626.0, up 6.16% from the prior year.
• Treasury Shares for Q1 2026 stood at $615765.0, down from $752626.0 in the prior quarter.
• The five-year high for Treasury Shares was $1.0 million in Q4 2022, with the low at -$1.0 million in Q3 2022.
• Historically, Treasury Shares has averaged $153907.3 across 4 years, with a median of $615765.0 in 2026.
• The largest YoY upside for Treasury Shares was 145.28% in 2022 against a maximum downside of 697.01% in 2022.
• Catalyst Pharmaceuticals' Treasury Shares stood at $1.0 million in 2022, then retreated by 29.1% to $708960.0 in 2024, then rose by 6.16% to $752626.0 in 2025, then decreased by 18.18% to $615765.0 in 2026.
• The last three Treasury Shares figures came in at $615765.0 (Q1 2026), $752626.0 (Q4 2025), and $708960.0 (Q4 2024), per Business Quant data.